Watson Laboratories, Inc. Faces FDA Proposal to Withdraw Approval of Oxycodone Hydrochloride and Ibuprofen Tablets ANDA

Summary

The FDA is proposing to withdraw approval of an abbreviated new drug application for oxycodone hydrochloride and ibuprofen tablets due to repeated failure to submit required data, and is offering the holder an opportunity to request a hearing on the proposal.